NCT07568756Not yet recruitingPhase 2
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation
Source: ClinicalTrials.gov · Last updated 6 May 2026
Brief summary (registry, in English)
This is a phase II single arm, open-label clinical trial determining diagnostic accuracy of Flotufolastat F18 PET in subjects with prostate adenocarcinoma. These are subjects who have not previously received treatment for prostate cancer.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 28 Apr 2026
- Start date
- May 2026
- Primary completion date
- May 2028
- Lead sponsor
- University of California, Irvine
- Diseases
- Prostate cancer
- NCT number
- NCT07568756
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 60
- From May 2026 to the primary completion date, May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior treatment for any prostate malignancy (e.g. radiation, focal therapy, or systemic therapy)
Other illness
- Genomic classifiers (e.g. Decipher) signifying intermediate or high-risk disease
- High-risk prostate cancer (diagnosed by biopsy)
- Bilateral prostatic lobe disease
Other
- PSA \>10
Who the study is looking for
- Age 18 years or greater at time of consent
- Prostate adenocarcinoma (no other histologic subtypes allowed)
- Prostate Cancer planned to be treated by focal therapy (e.g. cryotherapy, HIFU, or NanoKnife)
- Multiparametric-MRI imaging planned
- Planned pre- and post- treatment MRI-fusion biopsy
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chao Family Comprehensive Cancer Center, University of California, Irvine Coordinator of this site? Confirm its status | Orange | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.